Necrotic cell death releases histones, which act as inflammatory damage-associated molecular patterns (DAMPs). Lai, Cruz and Rock (Immunity 2020) identified the C-type lectin receptor Clec2d as a macrophage receptor that binds polybasic sequences in histone tails and, without signaling on its own, promotes TLR9-dependent cytokine responses to histone–DNA complexes (nucleosomes, neutrophil extracellular traps) and contributes to tissue injury in vivo. The central mechanistic question they left open — how Clec2d-bound histone–DNA complexes actually engage and activate endosomal TLR9, i.e. whether Clec2d physically interacts with TLR9 or acts purely by trafficking/chaperoning its cargo, and whether Clec2d affects TLR9 signaling beyond ligand delivery — remains unresolved. A linked open question is the ligand scope of Clec2d: whether other polybasic DAMPs such as HMGB1 and defensins, and histones of lower eukaryotes or pathogens, are bona fide Clec2d ligands. Later work extended the Clec2d–TLR9 axis to microglia and endothelium, identified fungal polysaccharide ligands and CLEC2D–TLR2 heterodimers, and produced first in vivo evidence both for benefit of Clec2d blockade (burn-induced vascular leakage) and for harm of Clec2d ablation (sepsis mortality), but the recognition mechanism and ligand-repertoire questions stand.

Background

When cells die by necrosis, their intracellular contents are released and act as damage-associated molecular patterns (DAMPs) — endogenous molecules that activate pattern-recognition receptors on innate immune cells and drive sterile inflammation, the inflammation that occurs without infection. Among nuclear DAMPs, histones are prominent: these highly conserved, positively charged DNA-packaging proteins are toxic to endothelium and parenchyma when extracellular, and stimulate inflammatory cytokine production; extracellular histones contribute to pathology in sepsis, trauma, ischemia-reperfusion injury, and drug-induced liver injury. Histones circulate mainly as nucleosomes (the histone octamer wrapped with DNA) or within neutrophil extracellular traps (NETs), web-like structures of DNA and histones extruded by activated neutrophils, so that histones and DNA are usually presented to the immune system together.

How immune cells recognize extracellular histones was poorly understood until Lai, Cruz and Rock (Immunity 2020) performed a targeted reporter screen of C-type lectin receptors (CLRs — a family of myeloid pattern-recognition receptors with a carbohydrate-binding lectin domain, some of which, like Clec9a and Mincle, already sense necrotic-cell DAMPs). They identified Clec2d as a receptor for necrotic-cell ligands and biochemically purified histones — free, nucleosomal, or NET-bound — as its ligands. Clec2d (mouse C-type lectin domain family 2 member D, also called Clr-b; human ortholog CLEC2D/LLT1/OCIL) was previously known mainly as a ligand of natural-killer-cell inhibitory receptors (NKR-P1B/D in mouse, CD161 in human) and as a binder of sulfated glycosaminoglycans. Recognition is sequence-based, not carbohydrate-based: Clec2d binds polybasic (lysine/arginine-rich) motifs in the N-terminal tails of histones H2A/H2B/H3/H4 and the C-terminal tail of H1, and post-translational modifications that neutralize lysine positive charge, such as acetylation, abolish binding.

Functionally, the picture is unusual. Clec2d lacks ITAM motifs (the tyrosine-based signaling module used by activating CLRs to recruit the kinase Syk), and histone binding to Clec2d provokes no detectable Syk, MAP-kinase, or NF-κB activation and no consistent cytokine production. Instead, Clec2d localizes to the plasma membrane and to late endosomes, and it augments cytokine responses to histone-bound DNA: stimulation of macrophages with histones plus CpG DNA (DNA containing unmethylated CpG dinucleotide motifs, the ligand of TLR9 — Toll-like receptor 9, the endosomal innate sensor of DNA) or with physiological nucleosomes produces TLR9-dependent responses that are strongly reduced in Clec2d-deficient macrophages. Thus Clec2d appears to act as a chaperone or delivery receptor that carries its histone–DNA cargo into TLR9-containing endosomes, analogous to how CD14 hands lipopolysaccharide to TLR4/MD2. In vivo, Clec2d-deficient mice mount reduced proinflammatory cytokine responses to injected histones and show less collateral tissue damage and better survival in acetaminophen-induced hepatotoxic liver injury.

The mechanistic gap is the last step of this pathway. TLR9 is synthesized in the endoplasmic reticulum and traffics to endosomes, where it proteolytically matures and recognizes internalized DNA; how the Clec2d-bound histone–DNA complex hands over its DNA to, or otherwise activates, TLR9 is unknown. The source paper states this explicitly: how histone–DNA complexes bound to Clec2d interact with Tlr9, and whether Clec2d affects Tlr9 signaling in other ways, remains to be determined. Because several other DAMPs also carry polybasic stretches — notably HMGB1 (high-mobility group box 1, a nuclear alarmin released by necrotic cells) and defensins (small cationic antimicrobial peptides of epithelial and neutrophil origin) — and because histone tail sequences are conserved across eukaryotes, the same paper asked whether Clec2d's ligand repertoire extends beyond mammalian histones, which would make it a general polybasic-sequence pattern-recognition receptor.

Problem Statement

Determine the molecular mechanism by which Clec2d promotes TLR9-dependent inflammatory responses to histone-containing DAMPs, and define how broad Clec2d's ligand repertoire is. Both components serve one objective: a mechanistic account of what Clec2d recognizes and how that recognition is coupled to endosomal TLR9 activation.

Mechanistic core: it is established that Clec2d binds polybasic histone-tail sequences, localizes to the plasma membrane and late endosomes, and that histone–DNA-driven, TLR9-dependent cytokine responses of macrophages are augmented by Clec2d without any detectable intrinsic signaling by Clec2d itself. What remains to be determined is (i) how histone–DNA complexes bound to Clec2d engage endosomal TLR9 — in particular, whether Clec2d physically interacts with TLR9 (for example as a receptor heterodimer or contact on the endosomal membrane, analogous to the CLEC2D–TLR2 heterodimers reported for responses to β-glucan, a fungal cell-wall polysaccharide) or instead acts purely as a chaperone that routes its cargo into TLR9-positive endosomes via a defined uptake route, endosomal sorting step, or fusion event; and (ii) whether Clec2d affects TLR9 signaling dynamics in any way beyond ligand delivery. A complete answer identifies the operative molecular step or interaction — the binding surfaces and/or the trafficking route and endosomal compartment involved — and shows, by targeted perturbation of those steps, that they are necessary for the Clec2d-dependent component of TLR9 activation by physiological ligands (nucleosomes and NET-derived histone–DNA complexes, not only synthetic CpG oligonucleotides) in innate immune cells, with evidence that discriminates among the candidate mechanisms. For the task as a whole to be complete, the mechanistic core (i) and sub-question (ii) must both be addressed and the ligand-scope questions resolved; any single one of (i), (ii), or the ligand-scope questions may instead be reported as an independent partial result.

Ligand-scope component: determine whether other polybasic DAMPs — notably HMGB1 and certain defensins — are bona fide Clec2d ligands (with binding demonstrated in defined assays and mapped to the polybasic regions involved, and shown to have functional consequences), and whether Clec2d recognizes histones of lower eukaryotes or pathogens, for example parasite histones. Together these determine whether Clec2d is a general polybasic-sequence pattern-recognition receptor or a mammalian-histone-specific sensor, and whether Clec2d can couple pathogen-derived nuclear material to TLR9 activation.

References

  1. Lai JJ, Cruz FM, Rock KL (2020) Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue Injury. Immunity 52(1):123-135.e6. doi:10.1016/j.immuni.2019.11.013. https://doi.org/10.1016/j.immuni.2019.11.013
  2. Del Fresno C, Sancho D (2020) Clec2d Joins the Cell Death Sensor Ranks. Immunity 52(1):6-8. doi:10.1016/j.immuni.2019.12.015. https://doi.org/10.1016/j.immuni.2019.12.015
  3. Wu H, Bao H, Liu C, Zhang Q, Huang A, Quan M, Li C, Xiong Y, Chen G, Hou L (2022) Extracellular Nucleosomes Accelerate Microglial Inflammation via C-Type Lectin Receptor 2D and Toll-Like Receptor 9 in mPFC of Mice With Chronic Stress. Frontiers in Immunology 13:854202. doi:10.3389/fimmu.2022.854202. https://doi.org/10.3389/fimmu.2022.854202
  4. Li YN, Wang ZW, Li F, Zhou LH, Jiang YS, Yu Y, Ma HH, Zhu LP, Qu JM, Jia XM (2022) Inhibition of myeloid-derived suppressor cell arginase-1 production enhances T-cell-based immunotherapy against Cryptococcus neoformans infection. Nature Communications 13(1):4074. doi:10.1038/s41467-022-31723-4. https://doi.org/10.1038/s41467-022-31723-4
  5. Li F, Wang H, Li YQ, Gu Y, Jia XM (2023) C-type lectin receptor 2d forms homodimers and heterodimers with TLR2 to negatively regulate IRF5-mediated antifungal immunity. Nature Communications 14(1):6718. doi:10.1038/s41467-023-42216-3. https://doi.org/10.1038/s41467-023-42216-3
  6. Yang X, Zheng E, Sun X, Reynolds A, Gonzalez M, Hernandez Villamil J, Pando BD, Smith DJ, Yuan SY, Wu MH (2024) C-Type Lectin-2d Receptor Contributes to Histone-Induced Vascular Barrier Dysfunction During Burn Injury. Shock 61(4):592-600. doi:10.1097/SHK.0000000000002237. https://doi.org/10.1097/SHK.0000000000002237
  7. Stolarski AE, Lai JJ, Kim J, Rock KL, Remick D (2024) Genetic Ablation of the C-Type Lectin Receptor CLEC2D Increases Peritonitis Mortality, Inflammation, and Physiology Without Diminishing Organ Injury. Shock 62(3):437-446. doi:10.1097/SHK.0000000000002413. https://doi.org/10.1097/SHK.0000000000002413
  8. Huang Y, Jiang W, Zhou R (2024) DAMP sensing and sterile inflammation: intracellular, intercellular and inter-organ pathways. Nature Reviews Immunology 24(10):703-719. doi:10.1038/s41577-024-01027-3. https://doi.org/10.1038/s41577-024-01027-3
  9. Reis e Sousa C, Yamasaki S, Brown GD (2024) Myeloid C-type lectin receptors in innate immune recognition. Immunity 57(4):700-717. doi:10.1016/j.immuni.2024.03.005. https://doi.org/10.1016/j.immuni.2024.03.005
  10. Nicolaes GAF, Soehnlein O (2024) Targeting extranuclear histones to alleviate acute and chronic inflammation. Trends in Pharmacological Sciences 45(7):651-662. doi:10.1016/j.tips.2024.05.008. https://doi.org/10.1016/j.tips.2024.05.008